Literature DB >> 26492489

Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy.

G-R Joliat1, I Labgaa1, D Petermann1, M Hübner1, A-C Griesser2, N Demartines1, M Schäfer1.   

Abstract

BACKGROUND: Enhanced recovery after surgery (ERAS) programmes have been shown to decrease complications and hospital stay. The cost-effectiveness of such programmes has been demonstrated for colorectal surgery. This study aimed to assess the economic outcomes of a standard ERAS programme for pancreaticoduodenectomy.
METHODS: ERAS for pancreaticoduodenectomy was implemented in October 2012. All consecutive patients who underwent pancreaticoduodenectomy until October 2014 were recorded. This group was compared in terms of costs with a cohort of consecutive patients who underwent pancreaticoduodenectomy between January 2010 and October 2012, before ERAS implementation. Preoperative, intraoperative and postoperative real costs were collected for each patient via the hospital administration. A bootstrap independent t test was used for comparison. ERAS-specific costs were integrated into the model.
RESULTS: The groups were well matched in terms of demographic and surgical details. The overall complication rate was 68 per cent (50 of 74 patients) and 82 per cent (71 of 87 patients) in the ERAS and pre-ERAS groups respectively (P = 0·046). Median hospital stay was lower in the ERAS group (15 versus 19 days; P = 0·029). ERAS-specific costs were €922 per patient. Mean total costs were €56 083 per patient in the ERAS group and €63 821 per patient in the pre-ERAS group (P = 0·273). The mean intensive care unit (ICU) and intermediate care costs were €9139 and €13 793 per patient for the ERAS and pre-ERAS groups respectively (P = 0·151).
CONCLUSION: ERAS implementation for pancreaticoduodenectomy did not increase the costs in this cohort. Savings were noted in anaesthesia/operating room, medication and laboratory costs. Fewer patients in the ERAS group required an ICU stay.
© 2015 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26492489     DOI: 10.1002/bjs.9957

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

1.  Predictors of Short-Term Readmission After Pancreaticoduodenectomy.

Authors:  Rajesh Ramanathan; Travis Mason; Luke G Wolfe; Brian J Kaplan
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

Review 2.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

Authors:  A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

Review 3.  Enhanced recovery pathways in pancreatic surgery: State of the art.

Authors:  Nicolò Pecorelli; Sara Nobile; Stefano Partelli; Luca Cardinali; Stefano Crippa; Gianpaolo Balzano; Luigi Beretta; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Better clinical benefits and potential cost saving of an enhanced recovery pathways for laparoscopic adrenalectomy.

Authors:  Yue Yan; Jie Cheng; Kang Chen; Ting-Fang Liu; Guang Ning
Journal:  Gland Surg       Date:  2022-01

5.  COST-EFFECTIVENESS OF THE USE OF ACERTO PROTOCOL IN MAJOR DIGESTIVE SURGERY.

Authors:  José Eduardo de Aguilar-Nascimento; Alberto Bicudo-Salomão; Mara Regina Rosa Ribeiro; Diana Borges Dock-Nascimento; Cervantes Caporossi
Journal:  Arq Bras Cir Dig       Date:  2022-06-24

6.  Early enteral vs. oral nutrition after Whipple procedure: Study protocol for a multicentric randomized controlled trial (NUTRIWHI trial).

Authors:  Gaëtan-Romain Joliat; David Martin; Ismail Labgaa; Emmanuel Melloul; Emilie Uldry; Nermin Halkic; Ginette Fotsing; Alessandra Cristaudi; Pietro Majno-Hurst; Dionisios Vrochides; Nicolas Demartines; Markus Schäfer
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

7.  Cost-effectiveness comparisons of enhanced recovery after surgery (ERAS) vs. non-ERAS for esophageal cancer in China: a retrospective comparative cohort study.

Authors:  Meng Zhang; Hong Wang; Xiaoyang Wang; Luyao Zhang; Cong Shen; Caihua Tian; Xiaoxia Xu; Xiang Li; Zongze Li; Shao-Kai Zhang; Bin-Bin Han
Journal:  Ann Transl Med       Date:  2022-09

8.  Lessons learned from 300 consecutive pancreaticoduodenectomies over a 25-year experience: the "safety net" improves the outcomes beyond surgeon skills.

Authors:  Roberto Santoro; Roberto Luca Meniconi; Pasquale Lepiane; Giovanni Vennarecci; Gianluca Mascianà; Marco Colasanti; Eugenio Santoro; Giuseppe Maria Ettorre
Journal:  Updates Surg       Date:  2017-09-01

9.  Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter.

Authors:  Timothy L Fitzgerald; Catalina Mosquera; Nicholas J Koutlas; Nasreen A Vohra; Kimberly V Edwards; Emmanuel E Zervos
Journal:  Surg Res Pract       Date:  2016-08-25

10.  An enhanced recovery after surgery program for video-assisted thoracoscopic surgery anatomical lung resections is cost-effective.

Authors:  Michel Gonzalez; Etienne Abdelnour-Berchtold; Jean Yannis Perentes; Valérie Doucet; Mathieu Zellweger; Carlos Marcucci; Hans-Beat Ris; Thorsten Krueger; Fabrizio Gronchi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.